# Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases

> **NCT06077045** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 12775880 (actual)

## Conditions studied

- Influenza

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06077045
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-18
- **Primary completion:** 2023-07-04
- **Final completion:** 2023-07-04
- **Target enrollment:** 12775880 (ACTUAL)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06077045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06077045, "Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06077045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*